The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment
Open accessAbstract
In recent decades, chemotherapies targeting apoptosis have emerged and demonstrated remarkable achievements. However, emerging evidence has shown that chemoresistance is mediated by impairing or bypassing apoptotic cell death. Several novel types of programmed cell death, such as ferroptosis, necroptosis, and pyroptosis, have recently been reported to play significant roles in the modulation of cancer progression and are considered a promising strategy for cancer treatment. Thus, the switch between apoptosis and pyroptosis is also discussed. Cancer immunotherapy has gained increasing attention due to breakthroughs in immune checkpoint inhibitors; moreover, ferroptosis, necroptosis, and pyroptosis are highly correlated with the modulation of immunity in the tumor microenvironment. Compared with necroptosis and ferroptosis, pyroptosis is the primary mechanism for host defense and is crucial for bridging innate and adaptive immunity. Furthermore, recent evidence has demonstrated that pyroptosis exerts benefits on cancer immunotherapies, including immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T-cell therapy (CAR-T). Hence, in this review, we elucidate the role of pyroptosis in cancer progression and the modulation of immunity. We also summarize the potential small molecules and nanomaterials that target pyroptotic cell death mechanisms and their therapeutic effects on cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–207 of 207
Pyroptosis of MCF7 Cells Induced by the Secreted Factors of hUCMSCs
Jiao, Y., Zhao, H., Chen, G., Sang, X., Yang, L., Hou, Z., Si, W., & Zheng, B. (2018) · Stem Cells International · doi:10.1155/2018/5912194 · Cited by 30
G2/M Cell-Cycle Arrest and Apoptosis by n-3 Fatty Acids in a Pancreatic Cancer Model
Dekoj, T., Lee, S. K., Desai, S., Trevino, J. G., Babcock, T. A., Helton, W. S., & Espat, N. J. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2006.10.024 · Cited by 28
Gasdermin family: a promising therapeutic target for cancers and inflammation-driven diseases
Wu, D., Chen, Y., Sun, Y., Gao, Q., Yu, B., Jiang, X., & Guo, M. (2020) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00564-5 · Cited by 22
Self-citationGasdermins deliver a deadly punch to cancer
Shen, C. X., Pandey, A., & Man, S. M. (2020) · Cell Research · doi:10.1038/s41422-020-0316-7 · Cited by 18
Yu, J., Wu, Y., & Wang, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01420 · Cited by 16
PELP1 signaling contributes to medulloblastoma progression by regulating the NF‐κB pathway
Luo, Y., Li, M., Pratap, U. P., Viswanadhapalli, S., Liu, J., Venkata, P. P., Altwegg, K. A., Palacios, B. E., Li, X., Chen, Y., et al. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23152 · Cited by 15
Self-citationKril, I., Havrylyuk, A., Potomkina, H., & Chopyak, V. (2020) · Rheumatology International · doi:10.1007/s00296-020-04642-0 · Cited by 9
Cited by
Tong, X., Tang, R., Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01392-3 · Cited by 883
Metadata
- Authors
- Hsu, S.-K., Li, C.-Y., Lin, I.-L., Syue, W.-J., Chen, Y.-F., Cheng, K.-C., Teng, Y.-N., Lin, Y.-H., Yen, C.-H., & Chiu, C.-C.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2021
- Volume
- 11
- Issue
- 18
- Pages
- 8813-8835
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W3197859532
- Cited by
- 484
- References
- 207
- FWCI
- 20.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.